ATE414154T1 - Moraxella (branhamella) catarrhalis antigene - Google Patents

Moraxella (branhamella) catarrhalis antigene

Info

Publication number
ATE414154T1
ATE414154T1 AT02729696T AT02729696T ATE414154T1 AT E414154 T1 ATE414154 T1 AT E414154T1 AT 02729696 T AT02729696 T AT 02729696T AT 02729696 T AT02729696 T AT 02729696T AT E414154 T1 ATE414154 T1 AT E414154T1
Authority
AT
Austria
Prior art keywords
branhamella
moraxella
catarrhalis antigen
catarrhalis
antigen
Prior art date
Application number
AT02729696T
Other languages
English (en)
Inventor
Denis Martin
Josee Hamel
Bernard Brodeur
Stephane Rioux
Julie Couture
Original Assignee
Id Biomedical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Id Biomedical Corp filed Critical Id Biomedical Corp
Application granted granted Critical
Publication of ATE414154T1 publication Critical patent/ATE414154T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/04Drugs for disorders of the respiratory system for throat disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Otolaryngology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02729696T 2001-05-15 2002-05-15 Moraxella (branhamella) catarrhalis antigene ATE414154T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29065301P 2001-05-15 2001-05-15

Publications (1)

Publication Number Publication Date
ATE414154T1 true ATE414154T1 (de) 2008-11-15

Family

ID=23116982

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02729696T ATE414154T1 (de) 2001-05-15 2002-05-15 Moraxella (branhamella) catarrhalis antigene

Country Status (10)

Country Link
US (2) US7410645B2 (de)
EP (2) EP1392831B1 (de)
JP (2) JP2005500024A (de)
CN (2) CN1514879A (de)
AT (1) ATE414154T1 (de)
AU (1) AU2002302236B2 (de)
CA (1) CA2447017A1 (de)
DE (1) DE60229845D1 (de)
ES (1) ES2316563T3 (de)
WO (1) WO2002092625A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010136562A2 (en) * 2009-05-28 2010-12-02 Intercell Ag Moraxella catarrhalis antigens
CN110527740B (zh) * 2019-09-11 2022-03-22 东北农业大学 一种与印度南瓜强雌基因紧密连锁的分子标记、引物及应用
JP6964161B2 (ja) * 2020-04-06 2021-11-10 旭化成株式会社 検体中のモラクセラ・カタラーリス菌を検出するための抗体、並びに斯かる抗体を用いてモラクセラ・カタラーリス菌を検出するための方法、試薬、及びキット

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431739A (en) 1979-11-05 1984-02-14 Genentech, Inc. Transformant bacterial culture capable of expressing heterologous protein
US4425437A (en) 1979-11-05 1984-01-10 Genentech, Inc. Microbial polypeptide expression vehicle
US4338397A (en) 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
WO1994006421A1 (en) 1992-09-16 1994-03-31 The University Of Tennessee Research Corporation Recombinant multivalent m protein vaccine
CA2123580C (en) 1992-09-16 2005-04-26 James B. Dale Antigen of hybrid m protein and carrier for group a streptococcal vaccine
US6716433B1 (en) 1997-09-12 2004-04-06 University Of Tennessee Research Foundation Group a streptococcal vaccines
EP1029052B1 (de) 1997-11-06 2010-08-04 Novartis Vaccines and Diagnostics S.r.l. Neisseriale antigene
GB9810084D0 (en) 1998-05-11 1998-07-08 Cortecs Uk Ltd Proteins
GB9817824D0 (en) 1998-08-14 1998-10-14 Smithkline Beecham Biolog Novel compounds
US6673910B1 (en) * 1999-04-08 2004-01-06 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to M. catarrhalis for diagnostics and therapeutics
EP1185658B1 (de) 1999-05-24 2008-06-04 GlaxoSmithKline Biologicals S.A. Neue verbindungen aus moraxella catarrhalis
AU1824101A (en) * 1999-06-18 2001-01-09 Elitra Pharmaceuticals, Inc. Nucleotide sequences of moraxella catarrhalis genome
GB9921691D0 (en) * 1999-09-14 1999-11-17 Smithkline Beecham Sa Novel compounds
AU8743001A (en) * 2000-08-28 2002-03-13 Aventis Pasteur Moraxella polypeptides and corresponding dna fragments and uses thereof
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition

Also Published As

Publication number Publication date
EP1392831A2 (de) 2004-03-03
US20090074807A1 (en) 2009-03-19
EP2025754A2 (de) 2009-02-18
WO2002092625A3 (en) 2003-07-10
EP2025754A3 (de) 2009-05-13
ES2316563T3 (es) 2009-04-16
CN1514879A (zh) 2004-07-21
JP2008289480A (ja) 2008-12-04
WO2002092625A2 (en) 2002-11-21
US20040236087A1 (en) 2004-11-25
JP2005500024A (ja) 2005-01-06
AU2002302236B2 (en) 2008-09-25
CN101063141A (zh) 2007-10-31
CA2447017A1 (en) 2002-11-21
US7410645B2 (en) 2008-08-12
EP1392831B1 (de) 2008-11-12
DE60229845D1 (de) 2008-12-24

Similar Documents

Publication Publication Date Title
ATE378403T1 (de) Transchromosomale transgen-nagetiere zur herstellung von humänen antikörpern
CY1113224T1 (el) Νεο αντισωμα αντι-ρlgf
DE60233955D1 (de) Spezifische bindungsmittel von human angiopoietin-2
IL189629A0 (en) Compositions containing human ctla-4 antibodies
CY1108387T1 (el) Ανταγωνιστες ανασυνδυασμενης il-18 χρησιμοι στη θεραπεια παθησεων που εμφανιζονται με διαμεσολαβηση της il-18
DK2000545T3 (da) Sammensætninger og fremgangsmåder til diagnose og behandling af lunge-tumor
TR200200472T2 (tr) Anti-Erb B2 antikorları ile tedavi için dozajlar
DE60136054D1 (de) Apoptose-induzierendes polypeptid
CY1114614T1 (el) Αντιγονα αιμοφιλου ινφλουεντσας και αντιστοιχα dna θραυσματα
SE0203825D0 (sv) Novel fused heterocycles and uses thereof
DE60232862D1 (de) Rekombinantes pockenvirus für chimäre proteine des menschlichen immunschwächevirus
ATE477274T1 (de) Gegen clostridium difficile gerichtete antikörper
DE60140972D1 (de) Antigene aus Cryptosporidium parvum, Antikörper dagegen und diagnostische und therapeutische Zusammensetzungen
BR0113099A (pt) Gene e proteìna relacionados com esquizofrenia
ATE414154T1 (de) Moraxella (branhamella) catarrhalis antigene
DE60335610D1 (de) Neoplasma-spezifische antikörper und deren verwendungen
ATE421586T1 (de) Moraxella (branhamella) catarrhalis antigene
DK1276495T3 (da) Anvendelse af rekombinante lungesurfactant-præparater til tidlig behandling af akutte lungesygdomme
EA200600956A1 (ru) Молекулы-антагонисты цитокинов
TR200003345T2 (tr) Moraxella Catarrhalıs'in bileşikleri
DE69921649D1 (de) Moraxella catarrhalis pilq proteine
DE60229871D1 (de) Moraxella (branhamella) catarrhalis polypeptide
WO2003018052A8 (en) Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments
ATE293693T1 (de) Moraxella catarrhalis antigen basb117
ATE293692T1 (de) Moraxella catarrhalis antigen basb120

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties